Complications include postradioembolization syndrome (PRS), hepatic complications, biliary complications, portal hypertension and lymphopenia. Complications resulting from extrahepatic deposition include<unk>  pneumonitis, gastrointestinal ulcers and vascular injury. Postradioembolization syndrome (PRS) includes fatigue, nausea, vomiting, abdominal discomfort or pain, and cachexia, occurring in 20-70% of patients. Steroids and anti-emetic agents may decrease the incidence of PRS. Hepatic complications include hepatic fibrosis leading to portal hypertension, radioembolization-induced liver disease (REILD), transient elevations in liver enzymes, and fulminant liver failure. Biliary complications include cholecystitis and biliary strictures. REILD is characterized by jaundice, ascites, hyperbilirubinemia and hypoalbuminemia developing at least 2 weeks-4 months after SIRT, in the absence of tumor progression or biliary obstruction. It can range in severity from minor to fatal and is related to (over)exposure of healthy liver tissue to<unk> .
Selective internal radiation therapy
Stereotactic radiation therapy
Chemoradiotherapy
Image-guided radiation therapy
External beam radiotherapy
Tomotherapy
Radiation therapy
Nerve-sparing surgery